Who
Melinda Brown
Director
Company insider
Files Form 4 as: Director, Precision BioSciences; SVP, Controller and PAO, Tapestry.
In numbers
- Trades disclosed
- 33
- Buys
- 6
- Sells
- 1
- Bought
- $57K
- Sold
- $341K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Nov 2016
- Last trade
- 25 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Sep 2026filed 29 Sep 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $7,1161,135 at $6.27 | filing |
| 25 Sep 2026filed 29 Sep 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $7,1161,135 at $6.27 | filing |
| 3 Jun 2026filed 5 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,979 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,979 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —21,000 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —21,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —21,000 | filing |
| 15 Dec 2025filed 17 Dec 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $6,8641,381 at $4.97 | filing |
| 22 Sep 2025filed 24 Sep 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $6,8461,400 at $4.89 | filing |
| 25 Jun 2025filed 27 Jun 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $6,9631,682 at $4.14 | filing |
| 3 Jun 2025filed 4 Jun 2025 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 27 May 2025filed 4 Jun 2025 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,826 at $0.00 | filing |
| 27 May 2025filed 4 Jun 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —9,826 | filing |
| 26 Mar 2025filed 28 Mar 2025 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $8,7351,839 at $4.75 | filing |
| 26 Dec 2024filed 30 Dec 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Bought | $14K3,016 at $4.55 | filing |
| 4 Jun 2024filed 6 Jun 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,826 at $0.00 | filing |
| 4 May 2024filed 7 May 2024 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,202 at $0.00 | filing |
| 4 May 2024filed 7 May 2024 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —4,202 | filing |
| 4 May 2023filed 8 May 2023 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —126,075 at $0.00 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Melinda Brown; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.